CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Rigel projects $285M-$295M 2026 total revenue while preparing mid-august VEPPANU launch

VEPPANUPositive
AI Analysis

Summary

Rigel Pharmaceuticals projects 2026 total revenue of $285M-$295M and plans to launch VEPPANU in mid-August.

Financial Highlights

Guidance

$285M-$295M for 2026

Importance:6/10
Sentiment:
0.50
commercial_launchrevenue_guidanceproduct_launch
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 5, 2026 2:10 AM

Read Original